Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
- PMID: 32926097
- PMCID: PMC7488867
- DOI: 10.1084/jem.20201012
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Abstract
Infection with SARS-CoV-2 is causing a deadly and pandemic disease called coronavirus disease-19 (COVID-19). While SARS-CoV-2-triggered hyperinflammatory tissue-damaging and immunothrombotic responses are thought to be major causes of respiratory failure and death, how they relate to lung immunopathological changes remains unclear. Neutrophil extracellular traps (NETs) can contribute to inflammation-associated lung damage, thrombosis, and fibrosis. However, whether NETs infiltrate particular compartments in severe COVID-19 lungs remains to be clarified. Here we analyzed postmortem lung specimens from four patients who succumbed to COVID-19 and four patients who died from a COVID-19-unrelated cause. We report the presence of NETs in the lungs of each COVID-19 patient. NETs were found in the airway compartment and neutrophil-rich inflammatory areas of the interstitium, while NET-prone primed neutrophils were present in arteriolar microthrombi. Our results support the hypothesis that NETs may represent drivers of severe pulmonary complications of COVID-19 and suggest that NET-targeting approaches could be considered for the treatment of uncontrolled tissue-damaging and thrombotic responses in COVID-19.
© 2020 Radermecker et al.
Conflict of interest statement
Disclosures: E. Cavalier reported "other" from Diasorin, Fujirebio, BioMerieux, IDS, Menarini, and Nittobo outside the submitted work. No other disclosures were reported.
Figures
Similar articles
-
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.J Exp Med. 2020 Dec 7;217(12):e20201129. doi: 10.1084/jem.20201129. J Exp Med. 2020. PMID: 32926098 Free PMC article.
-
Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.Cells. 2020 Jun 2;9(6):1383. doi: 10.3390/cells9061383. Cells. 2020. PMID: 32498376 Free PMC article.
-
SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure.Clin Sci (Lond). 2020 Jun 26;134(12):1295-1300. doi: 10.1042/CS20200531. Clin Sci (Lond). 2020. PMID: 32543703
-
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.Adv Biol Regul. 2020 Aug;77:100741. doi: 10.1016/j.jbior.2020.100741. Epub 2020 Jul 4. Adv Biol Regul. 2020. PMID: 32773102 Free PMC article. Review.
-
Early Insights into Immune Responses during COVID-19.J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8. J Immunol. 2020. PMID: 32513850 Review.
Cited by
-
An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results.Vaccines (Basel). 2022 Sep 16;10(9):1546. doi: 10.3390/vaccines10091546. Vaccines (Basel). 2022. PMID: 36146624 Free PMC article.
-
Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia.Biomedicines. 2022 Oct 20;10(10):2638. doi: 10.3390/biomedicines10102638. Biomedicines. 2022. PMID: 36289900 Free PMC article.
-
Building a human lung from pluripotent stem cells to model respiratory viral infections.Respir Res. 2024 Jul 15;25(1):277. doi: 10.1186/s12931-024-02912-0. Respir Res. 2024. PMID: 39010108 Free PMC article. Review.
-
Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis.Front Immunol. 2022 Sep 27;13:945583. doi: 10.3389/fimmu.2022.945583. eCollection 2022. Front Immunol. 2022. PMID: 36238303 Free PMC article.
-
Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation.Biomedicines. 2022 Mar 25;10(4):773. doi: 10.3390/biomedicines10040773. Biomedicines. 2022. PMID: 35453523 Free PMC article. Review.
References
-
- Ali R.A., Gandhi A.A., Meng H., Yalavarthi S., Vreede A.P., Estes S.K., Palmer O.R., Bockenstedt P.L., Pinsky D.J., Greve J.M., et al. . 2019. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat. Commun. 10:1916 10.1038/s41467-019-09801-x - DOI - PMC - PubMed
-
- Barnes B.J., Adrover J.M., Baxter-Stoltzfus A., Borczuk A., Cools-Lartigue J., Crawford J.M., Daßler-Plenker J., Guerci P., Huynh C., Knight J.S., et al. . 2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J. Exp. Med. 217 e20200652 10.1084/jem.20200652 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
